We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Niox Group Plc | LSE:NIOX | London | Ordinary Share | GB00BJVD3B28 | ORD 0.08P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.60 | 0.99% | 61.00 | 60.20 | 62.00 | 62.00 | 61.00 | 61.00 | 9,644 | 10:02:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 36.8M | 9.5M | 0.0224 | 27.23 | 256.17M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/6/2024 08:55 | Some massive trades yesterday 1 @ 1.6 million. Never seems to impact much on the price. Looked like a buy. Must be more share shuffling amongst the big holders. | earwacks | |
14/6/2024 11:50 | Wouldn’t surprise me. He has a lot of profit tied up here. Obviously not interested in a special dividend or any other dividend. Clearly he can see other opportunities and makes sense to diversify. If I could see better opportunities Imight do the same. At the moment I can’t see any better opportunities, not being in such a privileged position. I see Harwood also top sliced on June 6th and one of the directors transferred shares to his wife on the same day. So both funds holding about £100 million between them. Good they can find a new home for that many shares without crashing the share price Dont know about Griffiths but I think Harwood is usually pretty fully invested, so may be a case of just shifting stock around as he mentioned they do top slice. Should get a better idea of how growth is going next month. How much is the 600 million tax credit worth? To me that alone makes up an increasingly important factor as profits and revenues increase | earwacks | |
14/6/2024 11:11 | Think he is still selling. 1.3M buy just gone in at 68.3p. Even with a big seller there are an almost equal number of buyers so don't expect the share price to dip too much. | saadia110 | |
31/5/2024 14:37 | Holding up well since Griffiths reduced another 5% nearly. I think he reduced the day before it went ex div. Pretty impressive you can sell that many without denting the share price too much.He still holds 18%, about the same as Harwood. They have made a few million. Worth holding for the potential takeover and possible extra special dividend. Last year it paid for my flight to Australia. Not sure where to go this winter! | earwacks | |
22/5/2024 08:42 | Slightly strange that we are at house brokers target price again. Fairly quiet Agm announcement but inline with management expectations and a couple of million up on same time last year (not forgetting they paid out 10 million special dividend, so actually nearer 12 million up on last year!) but for the special dividend their cash position would be up over 30 per cent! Should get AGM result later today. Ex dividend tomorrow if motion carried. Maybe a little more about possible further special. Probably more news to come in July update regarding product developments. All resolutions passed ex div tomorrow, paid June 24th | earwacks | |
22/5/2024 08:16 | old warren said be prepared to pay a fair price for a good business. time will see you right. this one is not 'cheap' but is certainly priced fairly. | edwardt | |
22/5/2024 06:13 | Short and sweet, and bowling along nicely. Trading Update We are pleased to report that our business has continued to perform strongly in the year to date, in line with management expectations. In January 2024, NIOX settled returns claims amounting to £0.4m in relation to the discontinued business. The unaudited cash balance as at 30 April 2024 was £23.7m (31 December 2023: £19.9m), with no bank borrowings. NIOX expects to give a trading update in relation to the six months ended 30 June 2024 around the middle of July. | badday | |
20/5/2024 18:32 | Indeed we do. Will be interesting how the first four months compared to last year which turned in a whopping 21 percent rise. I would hope there would be a fair amount of news behind the recent steady rise. | earwacks | |
20/5/2024 17:57 | I take it we get a trading update on Wednesday? | badday | |
12/5/2024 12:22 | Buying volumes have been building for sometime after the fairly substantial pull back last autumn. Couldnt put my finger on one particular thing. Progress seems to be coming from a few direction, not least what to do with the mounting cash pile, and recognition of available options | earwacks | |
11/5/2024 08:46 | Seems we are not alone buying here . The copd angle was my reasoning to add - let's see what happens... | edwardt | |
09/5/2024 03:08 | Year end they were back to nearly 20 million cash. End of feb they had 22.5 million. They have another 4.4 million dollars from Beyond air in August with up to 6 million dollars in royalties there after. They have 2 million spend on thr development of pro Niox this year. I think Mills thought they would finish the year with 30 million. Looks a bit conservative to me. I think they can do that after dividends the way they are going. That’s a shed load of money, over 10 percent of Market cap in cash generation per year! | earwacks | |
08/5/2024 19:56 | The special divi was announced at start of June last year about 6 weeks before the July trading statement. Who knows they might have better things to do with the money this year - I am happy either way. | thedudie | |
08/5/2024 15:55 | TU July 18th last year. I guess we won’t hear about another special dividend until then | earwacks | |
08/5/2024 15:36 | Odd ... AGM was announced to be on the 22nd May and there is usually a trading update then. | thedudie | |
08/5/2024 14:23 | Data released on 17th apparently... | edwardt | |
03/5/2024 10:11 | Thanks Ram. Yes of course mills was on the Bioquel board too. He certainly knows his onions. | earwacks | |
03/5/2024 03:33 | earwacks, Ian Johnson was persuaded to take the hot seat by Chris Mills. | rambutan2 | |
02/5/2024 09:37 | Some big trades today | johnyee 7 | |
02/5/2024 07:37 | Have been delving further back into Circassia history. This is looking one of the more bizar Aim stories and there have been many. Apparently cir floated at £3.60 back in the day. Something to do with cat allergies! Thats me. My partner has two. Nightmare, but we also have a dog to defend me. Anyway obviously cir was a complete crackpot company under old management and got badly tangled up with Astra. Guess who came out on top? However Ian Johnson, like Chris Mills I clocked when he took Bioquel on a very successful journey about the same time as Cir were in their early days. Quite how Johnson came to Cir to take the reigns I’m not sure, but he certainly worked his magic on it. Just watched an old video of Andy Brough (schroders)talking about how he always gets interested when he hears Chris Mills is involved on the board of a biotech. I remember Mills saying all the serious money had been made on Niox when it was 50p, and it couldnt make 60p under its own steam, inferring a buyout I guess. It went on up to 75p under its own steam with a little help from a special dividend payout. Subsequently it fell back a bit. People keep saying its expensive, but I feel that is only when looking at current valuations. I remember valuations in companies being a lot higher than this pre Covid. Recently Niox have offered employees a 3 year savings plan for shares at 51p which I find curious. In light of recent developments with COPD, the upgrading of a new FeNo diagnostic instrument (the old one having a 5 year max shelf life limit) and the development of a home diagnostic kit, I find myself thinking these shares are bloody cheap still. Incidentally Mills is on the board of EKF (I have a smaller portion) and has made two £100,000 this year, one very recently when they announced results which as expected were not great. But they make enzymes! Or are trying to. He also has connections with Vrci and Renx, (kidney diagnostics) both of which have come off the boil a bit. Tempted for a small position, but they would definitely stretch my risk appetite. And why not just stick with what you know, Niox! | earwacks | |
01/5/2024 17:36 | They say averaging up is always better than averaging down. I dipped in at 27p, adding a shed load at 34 and in the 40s. I think not in the 50s for some reason and 3 more purchases in the 60s. Have thought about it, but would have to sell something. Tempted. Always remember the story about Soros chastising one of his team boasting about what a great trade he had done, Soros just said why the hell didn’t you go all in! I agree there are at least two possible game changers to add to this. This could just be the tip of the iceberg. Well done | earwacks | |
01/5/2024 13:47 | added a few. probably the kiss of death. however the potential for copd could be a game changer. | edwardt | |
30/4/2024 08:23 | we all have some duffers - if we don't admit to them, we are liars! | edwardt | |
30/4/2024 07:58 | Edward. Sounds fantastic. If successful that doubly underestimates the potential for Niox. Even Chris Mills seems to have not understood Niox. I think it was last year he commented Niox couldn’t reach 60p under its own steam! It smashed through that in a couple of months. He has been very bullish and it was him that flagged up the humongous tax credit. Personally I thought a target by one broker of £1.20 under its own steam was not pie in the sky considering 95 percent of their market is up for grabs. Requires replacing every 5 years depending on usage. Mills did point out this is a razor blade stock. Sounds like they have also reinvented another Gillette. dividend declared for next months and possibly another special on the cards. Have to admit this is now about a third of my portfolio and am not interested in top slicing. I have a few duffers in my portfolio but would rather kick them out frankly. My best pick since Arm holdings. Gl | earwacks |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions